Accredited Provider

This activity is provided by American College of Endocrinology in collaboration with The France Foundation.

Accreditation Statement

The American Association of Clinical Endocrinologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).

Upon completion of the activity, participants should be able to:

• Review traditional approaches to monitoring glucose
• Discuss continuous glucose monitoring (CGM) and the role it plays in managing patients with diabetes
• Identify patients for whom CGM use is appropriate
• Interpret CGM results
• Involve patients in interpretation of CGM results
• Use CGM results to provide continued support for patients with diabetes in the primary care setting

This educational initiative is intended for primary care clinicians who care for patients with diabetes.

As endocrine disorders are on the rise, it is very important that primary care providers take a role in patient management.

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures:

The faculty listed below report that they have relevant financial relationships to disclose:

• Anne Peters, MD, serves on advisory boards for Abbott Diabetes Care, Lilly, NovoNordisk, AstraZeneca, Vertex, Medscape, and Zealand. She does research funding for Dexcom, Insulet, and Abbott Diabetes Care. She also reports stock options for Omada Health and Teladoc.

• Archana Sadhu, MD, FACE, serves on the speakers bureau for Sanofi Aventis
• Jay Shubrook, DO, FACOFP, FAAFP, serves on an advisory board for Bayer, NovoNordisk, and Sanofi

The following faculty report that they have no relevant financial relationships to disclose:

• Jane Jeffrie Seley, DNP, MSN, MPH, GNP, CDE, BC-ADM, CDTC, FAADE, FAAN

Disclosure of Unlabeled Use

AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by independent educational grants from Abbott, Lilly, and Medtronic.

Copyright 2021, AACE. All rights reserved. No part of this enduring material may be reproduced or transmitted in any other form or by any other means, electronic or mechanical, without first obtaining written permission from AACE.